🏛️ Verified NIH Record • Updated 2025-11-20
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) (NCT06660173)
A Study to Evaluate the Efficacy, Safety & Tolerability of Maridebart Cafraglutide in Adults With T2DM
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Amgen
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.
Who can join: Review the eligibility criteria below.
Location: Accel Research Site - Birmingham Clinical Research Unit — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (96 Sites)
Showing the first 25 of 96 sites.
- Accel Research Site - Birmingham Clinical Research Unit — Birmingham, Alabama
- Anaheim Clinical Trials — Anaheim, California
- Hope Clinical Research LLC — Canoga Park, California
- Orange County Research Center — Lake Forest, California
- San Jose Clinical Trials — San Jose, California
- Northeast Research Institute - Neri — Fleming Island, Florida
- New Horizon Research Center — Miami, Florida
- Florida Institute for Clinical Research — Orlando, Florida
- Conquest Research - Winter Park — Winter Park, Florida
- Accel Research Site - Neurostudies — Decatur, Georgia
- Cedar Crosse Research and Health Care — Chicago, Illinois
- Tandem Clinical Research - Marrero — Marrero, Louisiana
- DM Clinical - Detroit — Southfield, Michigan
- Montana Medical Research — Missoula, Montana
- Physicians East — Greenville, North Carolina
- Diabetes and Endocrinology Associates of Stark County Inc — Canton, Ohio
- Alliance for Multispecialty Research — Norman, Oklahoma
- Trial Management Associates - Myrtle Beach — Myrtle Beach, South Carolina
- FutureSearch Trials of Neurology — Austin, Texas
- Velocity Clinical Research - Dallas — Dallas, Texas
- DM Clinical Research - Cyfair Clinical Research Center — Houston, Texas
- Southern Endocrinology Associates PA — Mesquite, Texas
- Be Well Clinical Studies — Round Rock, Texas
- Diabetes and Glandular Disease Clinic — San Antonio, Texas
- DM Clinical Research - Martin Diagnostic Clinic — Tomball, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 2 Diabetes Mellitus (T2DM)
- Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations — Greenfield, Massachusetts
- Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes (T2DM) — Zacatecas City, Zacatecas
- BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes — Mexico City, Cuauhtémoc
- Cohort Study of Metabolic Disease and Hypertension — Mexico City, Mexico City
- HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide — Nashville, Tennessee
Explore by condition: All Type 2 Diabetes Mellitus (T2DM) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.